HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Negative modulation of mitochondrial oxidative phosphorylation by epigallocatechin-3 gallate leads to growth arrest and apoptosis in human malignant pleural mesothelioma cells.

Abstract
Increasing evidence reveals a large dependency of epithelial cancer cells on oxidative phosphorylation (OXPHOS) for energy production. In this study we tested the potential of epigallocatechin-3-gallate (EGCG), a natural polyphenol known to target mitochondria, in inducing OXPHOS impairment and cell energy deficit in human epitheliod (REN cells) and biphasic (MSTO-211H cells) malignant pleural mesothelioma (MMe), a rare but highly aggressive tumor with high unmet need for treatment. Due to EGCG instability that causes H2O2 formation in culture medium, the drug was added to MMe cells in the presence of exogenous superoxide dismutase and catalase, already proved to stabilize the EGCG molecule and prevent EGCG-dependent reactive oxygen species formation. We show that under these experimental conditions, EGCG causes the selective arrest of MMe cell growth with respect to normal mesothelial cells and the induction of mitochondria-mediated apoptosis, as revealed by early mitochondrial ultrastructure modification, swelling and cytochrome c release. We disclose a novel mechanism by which EGCG induces apoptosis through the impairment of mitochondrial respiratory chain complexes, particularly of complex I, II and ATP synthase. This induces a strong reduction in ATP production by OXPHOS, that is not adequately counterbalanced by glycolytic shift, resulting in cell energy deficit, cell cycle arrest and apoptosis. The EGCG-dependent negative modulation of mitochondrial energy metabolism, selective for cancer cells, gives an important input for the development of novel pharmacological strategies for MMe.
AuthorsDaniela Valenti, Lidia de Bari, Gabriella Arcangela Manente, Leonardo Rossi, Luciano Mutti, Laura Moro, Rosa Anna Vacca
JournalBiochimica et biophysica acta (Biochim Biophys Acta) Vol. 1832 Issue 12 Pg. 2085-96 (Dec 2013) ISSN: 0006-3002 [Print] Netherlands
PMID23911347 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2013 Elsevier B.V. All rights reserved.
Chemical References
  • Reactive Oxygen Species
  • respiratory complex II
  • Adenosine Triphosphate
  • Catechin
  • Cytochromes c
  • epigallocatechin gallate
  • Catalase
  • Superoxide Dismutase
  • Electron Transport Complex II
  • Mitochondrial Proton-Translocating ATPases
  • Electron Transport Complex I
Topics
  • Adenosine Triphosphate (metabolism)
  • Apoptosis (drug effects)
  • Catalase (metabolism)
  • Catechin (analogs & derivatives, pharmacology)
  • Cell Cycle (drug effects)
  • Cell Proliferation (drug effects)
  • Cells, Cultured
  • Cytochromes c (metabolism)
  • Electron Transport Complex I (metabolism)
  • Electron Transport Complex II (metabolism)
  • Epithelial Cells (cytology, drug effects, metabolism)
  • Humans
  • Immunoblotting
  • Lung Neoplasms (drug therapy, metabolism, pathology)
  • Mesothelioma (drug therapy, metabolism, pathology)
  • Mesothelioma, Malignant
  • Mitochondria (drug effects, metabolism)
  • Mitochondrial Proton-Translocating ATPases (metabolism)
  • Oxidative Phosphorylation (drug effects)
  • Pleural Neoplasms (drug therapy, metabolism, pathology)
  • Reactive Oxygen Species (metabolism)
  • Superoxide Dismutase (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: